The genetic basis for FOP is linked to heterozygous mutations in the activin receptor A type I (ACVR1 or ALK2), with the R206H mutation present in over 95% of patients (Ravazzolo and Bocciardi, 2021). This evidence concerns the gene ACVR1 and fibrodysplasia ossificans progressiva.